| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.094 | 0.08 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |